Inhaled Nitric Oxide Study for Respiratory Failure in Newborns (NINOS)
The Randomized Inhaled Nitric Oxide Study (NINOS) in Full-Term and Nearly Full-Term Infants With Hypoxic Respiratory Failure
Sponsor: Medical Research Council of Canada
Terminated
Results showed statistically significant benefit in the experimental group
Other Hypertension, Pulmonary trials with similar outcome
A PHASE3 clinical study on Hypertension, Pulmonary and Infant, Newborn, this trial is terminated or withdrawn. The trial is conducted by Medical Research Council of Canada and has accumulated 8 data snapshots since 1995. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 3 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Feb 2017 — Oct 2017 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Oct 1995
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical Research Council of Canada
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
For direct contact, visit the study record on ClinicalTrials.gov .